Pan-Immune-Inflammation Value as a Novel Prognostic Biomarker for Advanced Pancreatic Cancer
Cureus · 11.10.2024
DOI: 10.7759/cureus.71251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 11.10.2024. Verfasst von Asim Armagan Aydin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, Health Science University Antalya Education and Research Hospital, Antalya, TUR. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Oncology, Health Science University Antalya Education and Research Hospital, Antalya, TUR.
- Department of Clinical Oncology, Istinye University School of Medicine, Istanbul, TUR.
- Department of Surgical Oncology, Health Science University Antalya Education and Research Hospital, Antalya, TUR.
Zitieren
APA
Aydin, A. A., Kayikcioglu, E., Unlu, A., Acun, M., Guzel, H. G., Yavuz, R., Ozgul, H., Onder, A. H., Ozturk, B., & Yildiz, M. (2024). Pan-Immune-Inflammation Value as a Novel Prognostic Biomarker for Advanced Pancreatic Cancer. Cureus. https://doi.org/10.7759/cureus.71251
Vancouver
Aydin AA, Kayikcioglu E, Unlu A, Acun M, Guzel HG, Yavuz R, et al. Pan-Immune-Inflammation Value as a Novel Prognostic Biomarker for Advanced Pancreatic Cancer. Cureus. 2024. doi:10.7759/cureus.71251
BibTeX
@article{Aydin2024,
author = {Aydin, Asim Armagan and Kayikcioglu, Erkan and Unlu, Ahmet and Acun, Mehmet and Guzel, Halil Goksel and Yavuz, Ridvan and Ozgul, Halit and Onder, Arif Hakan and Ozturk, Banu and Yildiz, Mustafa},
title = {Pan-Immune-Inflammation Value as a Novel Prognostic Biomarker for Advanced Pancreatic Cancer},
journal = {Cureus},
year = {2024},
doi = {10.7759/cureus.71251}
}
EUVIMED